India Attracts Funds, Not Expertise, To Open-Source Drug Discovery
This article was originally published in PharmAsia News
Executive Summary
India has moved into the open-source drug-discovery business to the extent it is attracting resources for developing orphan drugs, often overlooked by major companies.